From AGBT: Early Bird Rates End August 3: Save Over $200 for AGBT Precision Health https://conta.cc/4h4HSmU Join world-renowned leaders in precision medicine, genomics, AI, and rare disease this September in San Diego, California. Register by August 3 and Save Over $200 Connect with leading scientists, clinicians, biotechnology innovators, and healthcare leaders advancing precision medicine at the 2026 AGBT Precision Health Meeting, September 14–16 in San Diego, California. Explore the latest advances in AI, genomics, precision therapeutics, rare disease, and diagnostics while building valuable collaborations across academia, healthcare, and industry. Register Today: https://lnkd.in/ew9Bu-5a Why Attend AGBT Precision Health? ✅ Learn from world-renowned leaders in genomic medicine. ✅ Discover emerging technologies and clinical applications. ✅ Build collaborations and business opportunities. ✅ Experience AGBT's unique single-track program designed for meaningful scientific discussions and networking. ✅ Present your latest research with leaders across genomics and healthcare. Early Bird Registration Rates End August 3 Register today and save over $200. Complete a short form on the link below to receive an additional $100 discount and gain access to the 2025 AGBT Precision Health Meeting Book. Get Extra $100 Off: https://lnkd.in/ew9Bu-5a Meet Some of Our Featured Speakers Niall Lennon Director of Genomics, Broad Institute of MIT & Harvard and Chief Scientific Officer, Broad Clinical Labs. GUINNESS WORLD RECORDS™ recipient for fastest DNA sequencing technique. Alexis Battle Professor, Johns Hopkins University and pioneer in applying AI and machine learning to genomic and health data. Kiran Musunuru Cardiologist and Professor, Perelman School of Medicine at the University of Pennsylvania. He was named one of TIME's 100 Most Influential People of 2026. View the Full Agenda: https://lnkd.in/g4a2pdNz Supported by Industry Leaders Join leading organizations including GeneDx, Nabsys, SeqOne, Illumina, Omega Bio-Tek, AstraZeneca, and Invivoscribe, Inc. "This conference is the right people doing the right things and discussing the right topics. They stay current and bring together a highly relevant audience." — Sponsor of Precision Health 2025 Become a Sponsor or Exhibitor: https://lnkd.in/e68AWvuX
Washington Oregon Biotech Networks
Biotechnology Research
Seattle, Washington 1,558 followers
Life science news and jobs from Washington and Oregon state, including #Seattle and #Portland. A Biotech Networks hub.
About us
Life science news and jobs from Washington and Oregon state, including #Seattle and #Portland. Part of Biotech Networks, connecting #biotech since 2008.
- Website
-
https://wobn.org
External link for Washington Oregon Biotech Networks
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Seattle, Washington
- Founded
- 2022
- Specialties
- biotechnology, life sciences, and biotechnologyjobs
Updates
-
Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network https://lnkd.in/gFnYq55v SEATTLE–(BUSINESS WIRE)–Xpress Genomics joins Parse Biosciences’ CSP program as the first Nordic partner, offering Evercode single cell sequencing to Swedish researchers Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
-
Bothell Firm Fetches $1.5B in Acquisition by Massachusetts Company https://lnkd.in/gZ-csERq Boston-area life sciences company Repligen Corp. is acquiring Bothell-based BioLife Solutions Inc. for $1.5B. This transaction will expand the reach and impact of BioLife Solutions’ portfolio, while providing their stockholders with immediate cash value and the opportunity to participate in Repligen’s future growth. The post Bothell Firm Fetches $1.5B in Acquisition by Massachusetts Company appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
-
News in the NW: Q4 2025 – Q2 2026 https://lnkd.in/gCKeYQuG Life Science Washington released its Life Science News in the Northwest newsletter for Q4 2025 – Q2 2026, highlighting Washington’s $43.4B life sciences economic impact and the sectors’ continued expansion despite broader economic challenges. Explore Washington’s 50% employment growth over the past decade, ongoing investment in innovation, and the major funding deals and AI projects shaping one of the nation’s leading life science clusters. The Life Science News in the NW quarterly newsletter offers local business leaders, economic development professionals, and policymakers an inside look at the latest news driving Washington’s life sciences industry forward. The post News in the NW: Q4 2025 – Q2 2026 appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
-
UW Launches New Institute to Advance AI-Driven Drug Discovery and Development https://lnkd.in/gMaVp2nx The University of Washington has opened the Institute for Innovations in Drug Delivery and Disposition (I2D3), a new research institute housed in the UW School of Pharmacy. The institute is led by three UW faculty members and brings together experts in AI, drug discovery, pharmacology, data science, and biotechnology to accelerate the development promising new therapies. The post UW Launches New Institute to Advance AI-Driven Drug Discovery and Development appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
-
Exclusive: A David Baker Spinout Launches AI Antibody Data Consortium with GSK, Boltz and Others https://lnkd.in/gdZJE5Zn A-Alpha Bio, a startup spun out of David Baker’s lab, led by David Younger, has launched a first-of-its-kind AI antibody data consortium with GSK, Boltz Bio, Dyno Therapeutics, and Cradle. The initiative aims to accelerate AI-driven antibody discovery by generating and sharing large-scale experimental data among members. The post Exclusive: A David Baker Spinout Launches AI Antibody Data Consortium with GSK, Boltz and Others appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
-
OHSU to downsize primate center, pursue alternative research https://lnkd.in/gfTH98cw OHSU’s board vote sets another planning process in motion, after a plan to transition the research center to a sanctuary proved unworkable. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
-
EVS WIN Graduate, Dopl, Raises $6.3M to Bring Remote Robotic Ultrasounds to Rural Patients As it Pursues FDA Clearance https://lnkd.in/gKvt_j8w Seattle-based Dopl Technologies announced $6.3M in new funding to support the development and commercialization of a remotely operated robotic ultrasound system. The telerobotic platform combines robotics, AI, computer vision, and haptic feedback to improve access to ultrasound care and bring expert imaging to patients everywhere. The post EVS WIN Graduate, Dopl, Raises $6.3M to Bring Remote Robotic Ultrasounds to Rural Patients As it Pursues FDA Clearance appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
-
First Ever Bioscience Infrastructure and Ecosystem Building Grant and Spokane Early-Stage Grant Awardees Announced https://lnkd.in/gfG2inWD The Health Sciences and Services Authority (HSSA) of Spokane announced the first recipients of Bioscience Infrastructure and Ecosystem Building Grants and Spokane Early-Stage Grants. The awards recognize organizations helping strengthen the region’s bioscience ecosystem and support future economic growth. The post First Ever Bioscience Infrastructure and Ecosystem Building Grant and Spokane Early-Stage Grant Awardees Announced appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
-
UW to Break Ground on $191M Chemical Sciences Building This Fall https://lnkd.in/gdXTMt2n The University of Washington will break ground this fall on a $191M chemistry building to modernize chemistry teaching and research. The new facility will replace outdated systems and research spaces, expanding UW’s capacity for chemistry education, molecular engineering, and related scientific research. The post UW to Break Ground on $191M Chemical Sciences Building This Fall appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks